MOSAIC at Bio-IT World Europe 2023

“A lot of people are doing generative AI without having a biology step,” says Thomas Clozel. The Owkin approach, instead, prioritizes biological discovery through AI across the entire drug discovery and development pipeline. 

On the 29th November 2023, Owkin’s Joseph Lehár and other experts in the field participated in a panel discussion at #BioITExpo about the scientific vision of MOSAIC and shared updates on the initiative’s first six months.

Read the article in BIO-IT World https://www.bio-itworld.com/news/2023/11/15/owkin-s-generative-ai-vision-for-understanding-biology